Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Cancer Treat Rep ; 69(11): 1275-7, 1985 Nov.
Article in English | MEDLINE | ID: mdl-3867402

ABSTRACT

Patients with advanced inoperable or recurrent adenocarcinoma of the stomach received an iv bolus of epirubicin (75 mg/m2) every 3 weeks. Partial responses were observed in four of 24 evaluable patients (17%). Treatment was generally well tolerated; a drop in left ventricular ejection fraction was observed in one patient who had received 450 mg/m2 of epirubicin.


Subject(s)
Doxorubicin/therapeutic use , Stomach Neoplasms/drug therapy , Adenocarcinoma/drug therapy , Adult , Aged , Anemia/chemically induced , Doxorubicin/adverse effects , Drug Evaluation , Epirubicin , Female , Humans , Male , Middle Aged , Stroke Volume/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL